Diabetes, weight-loss meds ‘out of reach’ for many, I-MAK says Firms defend actions; Lilly calls report ‘grossly inaccurate’ Novo Nordisk A/S and Eli Lilly & Co. are using dense clusters of patents to ...

That's what Microsoft will be doing in April and May, with the Microsoft AI Skills Fest. It's a little odd, but it also looks like it might be a heck of a lot of fun. Microsoft's AI Skills Fest ...

Shares of AstraZeneca (AZN), Pfizer (PFE), Eli Lilly (LLY), Novo Nordisk (NVO), Johnson & Johnson (JNJ), GSK (GSK), and Sanofi (SNY) all declined. Gold futures climbed and the yield on the 10-year ...

The results could be harmful to them in more ways than one. Despite this issue, Eli Lilly remains a top stock to buy. As everyone who follows equity markets knows, stocks are feeling the heat from ...

Following a three-day selloff amid market turmoil attributed to the Trump administration’s sweeping tariffs announced last week, Eli Lilly (NYSE:LLY) shares traded higher in the premarket on ...

INDIANAPOLIS — Eli Lilly and Company says it's suing an Indianapolis-based weight loss clinic that it claims is misleading patients about drugs being sold. Lilly claims Premier Weight Loss is selling ...

April 8 - Eli Lilly (NYSE:LLY) shares rose about 5% Tuesday morning after Goldman Sachs (NYSE:GS) upgraded the pharmaceutical giant to Buy from Neutral, citing confidence in its leadership in the fast ...

‘Before asking for more Headcount and resources, teams must demonstrate why they cannot get what they want done using AI.’ ‘Before asking for more Headcount and resources, teams must ...

VILLE PLATTE, La. (KLFY) — An arrest has been made in the fatal Ville Platte shooting that occurred at the Gabriel Villa Apartment Complex on April 2. Officials said Tijuan Sims, 24, turned ...

Cassie Lang hasn't proven to be the natural successor we imagined, and Evangeline Lilly has supposedly retired from acting. That puts the pressure on Paul Rudd to pick up the slack and prove he ...

Eli Lilly & Co.’s shares fell Monday morning after the Trump administration spiked a plan late last week to pay for obesity drugs for Medicare patients. The Centers for Medicare and Medicaid ...

Tariff extension to pharma could hit generic drugmakers hardest, given narrow margins and ex-US API sourcing. FDA layoffs, CBER exit, and 503A/503B rule shifts may delay reviews, with GLP-1 ...